Gonadocorticoids linked to increased odds of lichen planopilaris and frontal fibrosing alopecia in women and men

Phase 3 trials show significant reduction in total lesion count versus Oracea and placebo

HPE performs as well as topical vitamin C for improvement in brown spot fractional area, wrinkle fractional area, luminosity

Demographic factors, including sex, age younger than 40 years, age 40 years and older, showed diverse associations with risk for outcomes

Age-adjusted CMM incidence rate was 0.99 per 1,000 from 2012 to 2016, marking an increase from previous years

Six high-risk clusters were identified with respect to county-level melanoma rate

The approval marks the first oral minocycline formulation for the papules and pustules characteristic of the condition

ICI users have about a twofold increase in risk for developing psoriasis, with findings consistent across all follow-up intervals

Male surgeons less often complain of upper back pain, but more often report lower back pain than female surgeons

C4C risk score achieved sensitivity of 80.46 ± 2.50 percent and specificity of 62.09 ± 1.90 percent, outperforming other models

All five known cases involved men who have sex with men; the rashes cleared up with antifungal treatments

Improvements of 30 percent in T-VASI and 50 percent in F-VASI reflect meaningful repigmentation between baseline, week 24

The IL-13 inhibitor offers a new first-line biologic treatment option for moderate-to-severe atopic dermatitis not well-controlled with topicals

Sensitivity of remote CCM was 89 percent, specificity was 64 percent for detection of malignancy

Risk for drug discontinuation higher due to ineffectiveness, adverse events for MTX, CsA versus dupilumab

Sensitive skin occurred on body sites that were and were not affected by hyperhidrosis

Benzene concentrations detected in 111 over-the-counter BPO drug products that were tested, maintained at room temperature

Melanoma less common among racial and ethnic minorities, but they still have increased rate of second primary melanoma

DSS similar with Mohs micrographic surgery, wide local excision treatment; findings persist in adjusted analysis

Serum and tissue levels of CXCL9 are reduced after 12 weeks of narrowband ultraviolet B phototherapy

Clinically meaningful efficacy outcomes observed at one year maintained to two years of treatment